Newsfeeds Archive - Page 3 of 194

1 minute read

News

Virgin Galactic Reported Flight Issue to FAA; Standard Post-flight Review Found An Alignment Pin Detached From The Mothership During Galactic 06 Flight; At No Time Did Detached Alignment Pin Pose Safety Impact To Vehicles Or Crew

February 5, 6:04 PM

Virgin Galactic Holdings, Inc. (NYSE:SPCE) (the “Company” or “Virgin Galactic”) today announced that during routine post-flight reviews following its most recent spaceflight, ‘Galactic

SPCE

1 minute read

Vanda Pharmaceuticals Announced Court Granted Vanda’s Motion For Summary Judgment On Its Claim Against The FDA

By Charles Gross

January 29, 8:08 PM

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced that the United States District Court for the District of Columbia granted Vanda's motion for summary judgment on its claim against the United States

VNDA

1 minute read

Ørsted Has Signed An Agreement With Eversource To Acquire Eversource’s 50% Share Of Sunrise Wind, A 924 Mw Offshore Wind Farm Which Would Deliver Power To New YorkØrsted has signed an agreement with Eversource to acquire Eversource’s 50 percent share o…

By Charles Gross

January 24, 6:32 PM

Ørsted has signed an agreement with Eversource to acquire Eversource's 50 percent share of Sunrise Wind, a 924 MW offshore wind farm which would deliver power to New York. The acquisition is subject to the

1 minute read

Getaround Secured $20M in Financing, Following Strong Q3 2023 Results

By Charles Gross

January 23, 8:20 PM

Getaround (NYSE:GETR), the world's first connected carsharing marketplace, today announced a new debt facility with Mudrick Capital Management for up to $20 million in additional capital to provide

GETR

2 minute read

IGC Pharma Announced Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer’s

By Charles Gross

January 23, 10:21 AM

IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American: IGC) provides details on its drug candidate TGR-63, which targets amyloid-beta plaque and can potentially improve Alzheimer's disease treatment in a significant manner.

IGC

1 minute read

FDA
News

FDA Reported Monday It Is Requiring Boxed Warning For CAR-T Cancer Therapies

By Charles Gross

January 23, 6:13 AM

https://www.fda.gov/media/175627/download?attachment https://www.fda.gov/media/175626/download?attachment https://www.fda.gov/media/175625/download?attachment https://www.fda.gov/media/175624/download?attachment https://www.fda.gov/media/175622/download?attachment https://www.fda.gov/media/175623/download?attachment

BMY

1 minute read

Legal
News

Genmab Announced Earlier Today That Appeal Arbitrator In Its Second Arbitration Arising Under Its License Agreement With Janssen For Daratumumab Has Denied Genmab’s Appeal

By Charles Gross

January 22, 8:24 PM

Genmab A/S (NASDAQ:GMAB) announced today that the appeal arbitrator in its second arbitration arising under its license agreement with Janssen Biotech, Inc. (Janssen) for daratumumab has denied Genmab’s appeal. As

GMAB

1 minute read

Legal
News

Spruce Power Holding Reported Settlement Agreement; Co To Pay $19.5M To Settlement Fund For All Claims Asserted In Class Action Litigation

By Charles Gross

January 22, 6:39 PM

-8-K On December 6, 2023, the lead plaintiff and the defendants entered into a Stipulation and Agreement of Settlement (the “Settlement Agreement”) toresolve the Class Action Litigation. On January 18, 2024,

SPRU

1 minute read

News

Bristol-Myers Squibb Announced Opdivo In Combination With Cabometyx Demonstrates Long-term Survival Benefits After Four Years Of Follow-up In The Checkmate -9er Trial In First-line Advanced Renal Cell Carcinoma

By Charles Gross

January 22, 6:02 PM

Bristol Myers Squibb (NYSE:BMY) and Exelixis, Inc. (NASDAQ:EXEL) today announced four-year follow-up results from the CheckMate -9ER trial evaluating Opdivo® (nivolumab) in combination with CABOMETYX®

BMY

1 minute read

FDA
News

Incannex Received IRB Approval For RePOSA Phase 2/3 Clinical Trial Protocol To Assess IHL-42X Drug In Patients With Obstructive Sleep Apnea

By Charles Gross

January 17, 7:12 AM

Incannex Healthcare Inc. (NASDAQ:IXHL), (‘Incannex’ or the ‘Company’), a pharmaceutical company developing unique medicinal cannabinoid pharmacotherapies and psychedelic medicine

IXHL